In NSCLC, activation of tissue-resident NK cells were reported to have an exhausted phenotype (CD69 + CXCR6+), highlighting their noncytotoxic function resulting in poor anti-tumor immunity [12]. The gene discussed is CD69; the disease is neoplasm.